BAM (8-22) is a bioactive fragment containing aromatic and basic residues that modulate folding and recognition patterns. Its sequence supports analyses of neuropeptide processing pathways. Conformational tendencies facilitate spectroscopic evaluation. Researchers apply it in biochemical mapping of opioid-like peptide motifs.
CAT No: R0956
CAS No:412961-36-5
Synonyms/Alias:412961-36-5;BAM (8-22);VGRPEWWMDYQKRYG;BAM8-22;BAM(8-22);H-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-OH;BAM-22P (8-22);BAM-15;GTPL4058;CHEMBL3343989;Bovine adrenal medulla (8-22);BDBM224021;GLXC-27185;BAM 8-22;C91H127N25O23S;bovine adrenal medulla peptide 8-22;HB2922;AKOS024456764;BAM-22P (8-22) trifluoroacetate salt;DA-50934;FB110182;G14299;H-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-OH; H-VGRPEWWMDYQKRYG-OH;
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.